Wyburn-Mason syndrome is associated with unilateral retinal racemose hemangioma. Rarely, it presents with bilateral and symmetrical grade of malformation. We describe a 37-year old male, who presented with Wyburn-Mason syndrome presenting with bilateral but asymmetrical retinal hemangioma. The eye with advanced grade of hemangioma was complicated with exudation, intraretinal fluid, neurosensory detachment, and reduced vision. He was treated with one intravitreal injection of bevacizumab, after which both the intraretinal fluid and neurosensory detachment resolved. His vision improved and was maintained till 1 year of follow-up. [3] Grade I lesions are characterized by AV communications with abnormal capillary plexus, whereas grade II lesions lack a capillary bed. In grade III lesions, distinction between artery and veins becomes impossible.
Wyburn-Mason syndrome is a rare, congenitally acquired, vascular malformation. [1, 2] It is characterized by direct artery-to-vein communication in retina and ipsilateral central nervous system. [1] [2] [3] [4] [5] Archer et al. classified the retinal arteriovenous malformations (AVMs), also called retinal racemose hemangioma, into three grades according to their severity. [3] Grade I lesions are characterized by AV communications with abnormal capillary plexus, whereas grade II lesions lack a capillary bed. In grade III lesions, distinction between artery and veins becomes impossible. [4] The most characteristic feature of this malformation is its unilaterality. [1, 5] Only few cases of bilateral involvement have also been reported in literature. All these cases presented with a symmetrical grade of retinal hemangioma. [1, 5, 6] We describe clinical features and management of a patient with Wyburn-Mason syndrome who presented with bilateral but asymmetrical grade of retinal racemose hemangioma.
Case Report
A 37-year-old male presented with complaint of decreased vision in right eye for 4 months. His systemic history was unremarkable. Best-corrected visual acuity (BCVA) in right eye was 20/60 and left eye was 20/20. Ocular examination revealed round and normal reacting pupils with no relative afferent pupillary defect and parallel visual axes. Anterior segment examination in both the eyes was unremarkable. Posterior segment examination showed dilated and tortuous vessels with AV communication in both the eyes with hard exudates in the macular region in the right eye [ Fig. 1a and b] . While the AVMs in right eye were of grade II, AVMs present in left eye were of grade I. The periphery was normal in both the eyes. Fluorescein fundus angiography (FFA) showed normal arm-to-retina time and rapid transit time in both the eyes, non-leaky retinal AV communications in the left eye [ Fig. 1c] , and late leakage in the perifoveal area in the right eye [ Fig. 1d This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. the patient was diagnosed with incomplete Wyburn-Mason syndrome. [1] Optical coherence tomography examination showed hyporeflective lesions in the inner retinal layers of the perifoveal and peripapillary region suggestive of dilated vessels in both the eyes [Fig. 3a] ; hyperreflective lesions suggestive of hard exudates, intraretinal edema, and neurosensory detachment involving the fovea in the right eye [Fig. 3b] ; while the left eye showed no macular edema [Fig. 3c] .
The patient underwent one intravitreal injection of bevacizumab (IVB, 1.25 mg/0.05 mL) in his right eye. One month after the injection, BCVA in his right eye improved to 20/30. Both the intra-and subretinal fluid resolved and the exudates reduced. At 1-year follow-up, the patient maintained his BCVA at 20/30, while there was no recurrence of macular edema [ Fig. 3d] . The vision did not improve completely because of the presence of hard exudate clumps in the outer layers of the fovea.
Discussion
We presented clinical findings of a patient with Wyburn-Mason syndrome and bilateral retinal racemose hemangioma. After a thorough search, we could find only eight cases of bilateral retinal hemangioma.
[1,5,6] All the described cases had a symmetrical grade of retinal AVM in each eye. However, our patient presented with different grade of AVM in both the eyes. Second, these AVMs are usually stable without any signs of leakage on FFA. However, in this case the eye with the higher grade of AVM was complicated by exudation, macular edema, and decreased vision, and the FFA showed late leakage in the perifoveal area.
The cause of macular edema in such cases in debatable. Soliman et al. suggested that the probable site of leakage may be either the capillaries adjacent to the AVM or the anastomosing vessels. [5] The venous pressure in the shunt vessels is exposed to high arterial pressure due to the absence of a normal capillary network. [1] This elevated venous transmural pressure causes excessive backpressure in the venous capillaries around the anastomosis. The raised capillary pressure decompensates the delicate balance maintained by the starling forces and the capillaries start leaking. [5, 7] Various modalities of treatment for the intraretinal and subretinal fluid in racemose hemangioma have been described by different authors [ Table 1 ]. We investigated the role of intravitreal bevacizumab in the management of macular edema associated with retinal racemose hemangioma. Both intraretinal and subretinal fluid in our patient responded well to a single dose of IVB. The effect was maintained for 1 year, that is, the last date of follow-up. The exact mechanism through which bevacizumab reduces macular edema in these AVMs is unknown. It can be either due to the drug's ability to decrease the vascular permeability or due to its ability to reduce the number of dysplastic vessels. [2, 9] The limitation of this case study is the absence of a long-term follow-up, which can help us understand the natural course of the patient. It would be interesting to know whether the AVMs in the second eye also become decompensated.
Conclusion
IVB seems to be a safe and effective option for the treatment of maculopathy associated with retinal racemose hemangioma. Barreira et al. [4] 31/F NA 20/40 Intraretinal 3 IVB 1 year 20/20
Soliman et al. [5] 57/F NA 20/200 NA 2 Laser sessions 4 years 20/20
Onder et al. [7] 14/M NA 20/30 Intraretinal, subretinal 1 PST TA (20 mg) 1 month 20/20 Winter et al. [8] 
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